Chargement en cours...

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

BACKGROUND: OnabotulinumtoxinA is approved for the prevention of headache in those with chronic migraine (CM); however, more clinical data on the risk-benefit profile for treatment beyond one year is desirable. METHODS: The Chronic Migraine OnabotulinuMtoxinA Prolonged Efficacy open Label (COMPEL) S...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Headache Pain
Auteurs principaux: Blumenfeld, Andrew M., Stark, Richard J., Freeman, Marshall C., Orejudos, Amelia, Manack Adams, Aubrey
Format: Artigo
Langue:Inglês
Publié: Springer Milan 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5799088/
https://ncbi.nlm.nih.gov/pubmed/29404713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0840-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!